II
ABBV icon

IFM Investors’s AbbVie ABBV Stock Holding History

IFM Investors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102M Buy
405,580
+44,160
+12% +$9.5M 0.68% 24
2026
Q1 		$78.6M Buy
361,420
+12,009
+3% +$2.66M 0.66% 21
2025
Q4 		$79.8M Buy
349,411
+4,114
+1% +$937K 0.67% 19
2025
Q3 		$76.2M Sell
345,297
-1,400
-0.4% -$285K 0.67% 24
2025
Q2 		$64.4M Buy
346,697
+12,093
+4% +$2.25M 0.61% 24
2025
Q1 		$70.1M Buy
334,604
+3,741
+1% +$727K 0.76% 21
2024
Q4 		$58.8M Sell
330,863
-29,681
-8% -$5.46M 0.6% 24
2024
Q3 		$71.2M Sell
360,544
-1,282
-0.4% -$239K 0.68% 21
2024
Q2 		$62.1M Buy
361,826
+2,082
+0.6% +$345K 0.63% 22
2024
Q1 		$65.5M Sell
359,744
-1,351
-0.4% -$233K 0.71% 21
2023
Q4 		$56M Buy
361,095
+3,372
+0.9% +$492K 0.68% 23
2023
Q3 		$53.3M Buy
357,723
+10,719
+3% +$1.57M 0.7% 22
2023
Q2 		$46.8M Buy
347,004
+16,715
+5% +$2.45M 0.61% 25
2023
Q1 		$52.6M Buy
330,289
+9,628
+3% +$1.47M 0.8% 19
2022
Q4 		$51.8M Buy
320,661
+12,893
+4% +$1.98M 0.87% 20
2022
Q3 		$41.3M Buy
307,768
+2,868
+0.9% +$412K 0.75% 22
2022
Q2 		$46.7M Buy
304,900
+20,137
+7% +$3.08M 0.82% 20
2022
Q1 		$46.2M Buy
284,763
+49,543
+21% +$7.2M 0.72% 22
2021
Q4 		$31.8M Sell
235,220
-649
-0.3% -$76.7K 0.58% 29
2021
Q3 		$25.4M Buy
235,869
+173
+0.1% +$19.8K 0.53% 36
2021
Q2 		$26.5M Buy
235,696
+42,379
+22% +$4.77M 0.54% 34
2021
Q1 		$20.9M Buy
193,317
+22,731
+13% +$2.43M 0.56% 35
2020
Q4 		$18.3M Buy
170,586
+23,636
+16% +$2.27M 0.58% 33
2020
Q3 		$12.9M Buy
146,950
+17,075
+13% +$1.61M 0.54% 37
2020
Q2 		$12.8M Sell
129,875
-17,526
-12% -$1.54M 0.66% 31
2020
Q1 		$11.1M Sell
147,401
-4,924
-3% -$419K 0.5% 43
2019
Q4 		$13.5M Sell
152,325
-7,443
-5% -$618K 0.48% 43
2019
Q3 		$12.1M Buy
159,768
+54,980
+52% +$3.77M 0.45% 47
2019
Q2 		$7.62M Buy
104,788
+6,863
+7% +$539K 0.43% 47
2019
Q1 		$7.89M Buy
97,925
+10,200
+12% +$834K 0.51% 43
2018
Q4 		$8.09M Buy
87,725
+7,616
+10% +$670K 0.65% 30
2018
Q3 		$7.58M Buy
80,109
+10,325
+15% +$979K 0.58% 35
2018
Q2 		$6.46M Buy
69,784
+20,071
+40% +$1.96M 0.61% 33
2018
Q1 		$4.71M Buy
49,713
+5,084
+11% +$558K 0.68% 30
2017
Q4 		$4.32M Sell
44,629
-79
-0.2% -$7.45K 0.68% 30
2017
Q3 		$3.97M Buy
44,708
+674
+2% +$51.3K 0.67% 33
2017
Q2 		$3.19M Buy
44,034
+11,010
+33% +$740K 0.57% 36
2017
Q1 		$2.15M Buy
33,024
+12,448
+60% +$783K 0.54% 38
2016
Q4 		$1.29M Buy
+20,576
New +$1.26M 0.61% 36

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

IFM Investors's ABBV Position: Q2 2026 in Review

IFM Investors increased its AbbVie (ABBV) stake by 12% in Q2 2026, buying an estimated $9.5M and bringing the position to 405,580 shares worth $102M. The position accounts for 0.68% of the portfolio, ranked #24.

IFM Investors first reported a position in ABBV in Q4 2016 and has held it in 39 quarters since. 1,432 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • IFM Investors held 405,580 shares of AbbVie worth $102M as of Q2 2026.
  • IFM Investors bought 44,160 AbbVie shares in Q2 2026, an estimated $9.5M.
  • AbbVie made up 0.68% of IFM Investors's portfolio in Q2 2026, its #24 holding.
  • IFM Investors first reported a position in AbbVie in Q4 2016 and has held it in 39 quarters since.
  • 1,432 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.